Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
Clinical Benefit
| Insufficient |
The actual benefit of CHONDROSULF 400 mg capsules and granules is insufficient to justify reimbursement by National Insurance. |
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
EyyuLh5WHsZpbv8Q
